• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PXT261218
Device Problem Migration (4003)
Patient Problem Complaint, Ill-Defined (2331)
Event Date 08/01/2020
Event Type  Injury  
Manufacturer Narrative
Report also includes (b)(4).
 
Event Description
Following was reported to gore: on (b)(6) 2012, a patient underwent endovascular treatment of an abdominal aortic aneurysm using gore® excluder® aaa endoprosthesis.On an unknown date, a ct imaging revealed aneurysm enlargement approximately 20mm, and a type ii endoleak from inferior mesenteric artery was suspected.In (b)(6) 2020, coil embolization was performed to treat the type ii endoleak.The patient tolerated the procedure.(above event was reported under mpdcase-(b)(4)).On an unknown date, a type iii endoleak(unknown whether component disconnection nor tear/disruption in graft material) and a type ii endoleak was suspected from a imaging.On (b)(6) 2020, re-intervention placing additional stent graft at the connection of the (b)(4) was performed.The physician elected to monitor type ii endoleak, and no treatment was performed for type ii endoleak.The patient tolerated the procedure.
 
Manufacturer Narrative
H6: code 213 - the review of the manufacturing paperwork verified that this lot met all pre-release specifications; h6: code 22 ¿ according to the gore® excluder® aaa endoprosthesis instructions for use, adverse events with may occur and/or require intervention including, but not limited to, endoleak.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE EXCLUDER AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10488929
MDR Text Key208130088
Report Number2953161-2020-01017
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132610204
UDI-Public00733132610204
Combination Product (y/n)N
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/31/2014
Device Model NumberPXT261218
Device Catalogue NumberPXT261218
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/12/2020
Initial Date FDA Received09/03/2020
Supplement Dates Manufacturer Received08/12/2020
Supplement Dates FDA Received09/21/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
-
-